Osteoporosis in Pemphigus: Steroids Are Not the Only Story
Keywords:
Pemphigus vulgaris, Glucocorticoids, Osteoporosis, Bone mineral density, Inflammatory cytokines, Steroid-induced bone lossReferences
Wohl Y, Dreiher J, Cohen AD. Pemphigus and osteoporosis: a case-control study. Arch Dermatol. 2010;146(10):1126–31. DOI:10.1001/archdermatol.2010.257.
Ghodsi SZ, Shahram F, Daneshpazhooh M, et al. Osteoporosis in patients with Pemphigus Vulgaris before steroid therapy. Acta Med Iran. 2014;52(12):879–83.
Srivastava RK, Sapra L. The rising era of "immunoporosis": role of immune system in the pathophysiology of osteoporosis. J Inflamm Res. 2022;15:1667–98. DOI:10.2147/JIR.S351918.
Timoteo RP, da Silva MV, Miguel CB, Silva DA, Catarino JD, Rodrigues Junior V, et al. Th1/Th17-related cytokines and chemokines and their implications in the pathogenesis of pemphigus vulgaris. Mediators Inflamm. 2017;2017:7151285. DOI:10.1155/2017/7151285.
van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39(12):1383–89. DOI:10.1093/rheumatology/39.12.1383.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ankan Gupta

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

